NEW INSIGHTS ON THE INVOLVING OF AMYLOID BETA PEPTIDE IN ALZHEIMER’S DISEASE PATHOLOGY

Alzheimer’s disease (AD) is the most common neurodegenerative disorder that affects millions of people worldwide causing massive economic burden and the number of cases is expected to rise dramatically. Currently, there is no treatment that can stop or reverse the effects of AD. This review attempts to present the current status of research, bio-pathological approach mechanisms, biomarkers and therapeutic interventions of AD.